Evoke Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Evoke Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 107% to $5,180,630. The net income raised on -$7,792,295 and profit margin reached -150%. Total operating expenses were $12,409,642.
Profit Margin
| 2014 | 0 | -13.24M | |
|---|---|---|---|
| 2015 | 0 | -12.12M | |
| 2016 | 0 | -10.74M | |
| 2017 | 0 | -12.22M | |
| 2018 | 0 | -7.56M | |
| 2019 | 0 | -7.09M | |
| 2020 | 23.02K | -13.26M | -57610.74% |
| 2021 | 1.61M | -9.02M | -558.03% |
| 2022 | 2.50M | -8.16M | -325.36% |
| 2023 | 5.18M | -7.79M | -150.41% |
EVOK Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 5.18M | 2.50M | 1.61M | 23.02K | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 201.87K | 370.39K | 328.11K | 86.71K | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 4.97M | 2.13M | 1.28M | -63.69K | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 181.90K | 300.78K | 590.47K | 6.55M | 3.41M | 4.09M | 7.13M | 6.95M | 8.15M | 9.99M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 12.40M | 9.92M | 9.44M | 12.98M | 7.15M | 8.01M | 11.23M | 10.54M | 11.81M | 13.15M |
Operating income | -7.43M | -7.78M | -8.15M | -13.04M | -7.15M | -8.01M | -11.23M | -10.54M | -11.81M | -13.15M |
Other income (expenses), net | -361.40K | -437.99K | -386.30K | -107.32K | 28.79K | 433.39K | -998.83K | 597.61K | -303.16K | -97.64K |
Income before tax | -7.79M | -8.22M | -8.53M | -13.15M | -7.12M | -7.56M | -12.22M | -10.74M | -12.12M | -13.24M |
Income tax expense | 0 | -62.00K | 491.43K | 107.32K | -28.79K | -912.42K | -6.51K | 801.72K | 0 | 0 |
Net income | -7.79M | -8.16M | -9.02M | -13.26M | -7.09M | -7.56M | -12.22M | -10.74M | -12.12M | -13.24M |
Earnings per share | ||||||||||
Basic EPS | -27.97 | -2.6 | -3.37 | -74.91 | -3.82 | -5.47 | -118.21 | -13.81 | -269.13 | -316.23 |
Diluted EPS | -27.97 | -2.6 | -3.37 | -74.91 | -3.82 | -5.47 | -118.21 | -13.81 | -269.13 | -316.23 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |